• January -
    New product Launch - Pacimol® Active
    April -
    Whistle Blower Policy implemented.
    May -
    Ipca Sports Club wins the E-Merck Inter-Pharma Cricket Tournament.
    Ipca Sports Club wins Dreamz Trophy (T-20 & 40-overs format).
    July -
    Ipca clinical study entitled “Efficacy and safety of Hydroxychloroquine in the Treatment of Type 2 Diabetes Mellitus: A Double Blind, Randomized Comparison with Pioglitazone” is published in Current Medical Research and Opinion. This was one of the largest clinical studies conducted by Ipca. With this publication, Ipca’s total number of publications (including clinical and preclinical studies) has reached 35 publications.
    August -
    Ipca acquires formulations manufacturing unit located at Tarapur, Dist. Palghar, Maharashtra.
    New Domestic Marketing Ophthalmology Division 'Optima' launched.
    September -
    Dr. Manisha Premnath appointed as Additional Director of the Company.
    Ipca acquires high Potency oral solid Dosage Formulations manufacturing unit located at Pithampur (Dist. Dhar), Madhya Pradesh.
Copyright © Ipca Laboratories Ltd. 2012. All Rights Reserved.